Vir Biotechnology, Inc. VIR Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $68.56M-7.6% | $74.21M-13.9% | $86.18M-94.7% | $1.62B+47.5% | ||
| —— | $73.36M-12.1% | $83.42M-94.3% | $1.47B+42.7% | ||
| $455.97M-10.0% | $506.5M-12.6% | $579.72M+22.1% | $474.65M+5.9% | ||
| $92.07M-22.6% | $119.03M-31.8% | $174.44M+7.8% | $161.76M+0.6% | ||
| $547.88M-17.2% | $661.37M-14.2% | $770.49M-1.6% | $782.73M+16.0% | ||
| -$479.33M+18.4% | -$587.17M+14.2% | -$684.31M— | —— | ||
| -699.2%+92.1pp | -791.3%+2.8pp | -794%— | —— | ||
| $41.56M-35.1% | $64.06M+14.2% | $56.11M+171% | -$78.79M— | ||
| -$437.77M+16.3% | -$523.11M+16.7% | -$628.19M— | —— | ||
| —— | -$1.15M+91.2% | -$13.08M— | —— | ||
| -$437.99M+16.1% | -$521.96M+15.1% | -$615.12M— | —— | ||
| -638.9%+64.5pp | -703.4%+10.4pp | -713.8%— | —— | ||
| -$3.15+17.5% | -$3.82+16.8% | -$4.59— | —— | ||
| -$467.65M+18.3% | -$572.61M+13.9% | -$665.09M— | —— | ||
| -682.1%+89.5pp | -771.7%+0.1pp | -771.7%— | —— | ||
| -$479.33M+18.4% | -$587.17M+14.2% | -$684.31M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Vir Biotechnology, Inc.'s profit margins?
- Gross margin is 96.1% and operating margin is -720.8%, with a -676.0% net margin.
- Where does Vir Biotechnology, Inc.'s income statement data come from?
- Every line is extracted from Vir Biotechnology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.